These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1381 related items for PubMed ID: 30518405

  • 1. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
    Duan S, Huang W, Liu X, Liu X, Chen N, Xu Q, Hu Y, Song W, Zhou J.
    J Exp Clin Cancer Res; 2018 Dec 05; 37(1):304. PubMed ID: 30518405
    [Abstract] [Full Text] [Related]

  • 2. The up-regulated lncRNA DLX6-AS1 in colorectal cancer promotes cell proliferation, invasion and migration via modulating PI3K/AKT/mTOR pathway.
    Zhang JJ, Xu WR, Chen B, Wang YY, Yang N, Wang LJ, Zhang YL.
    Eur Rev Med Pharmacol Sci; 2019 Oct 05; 23(19):8321-8331. PubMed ID: 31646562
    [Abstract] [Full Text] [Related]

  • 3. ARHGAP9 inhibits colorectal cancer cell proliferation, invasion and EMT via targeting PI3K/AKT/mTOR signaling pathway.
    Sun J, Zhao X, Jiang H, Yang T, Li D, Yang X, Jia A, Ma Y, Qian Z.
    Tissue Cell; 2022 Aug 05; 77():101817. PubMed ID: 35679685
    [Abstract] [Full Text] [Related]

  • 4. Long non-coding RNA-SNHG7 acts as a target of miR-34a to increase GALNT7 level and regulate PI3K/Akt/mTOR pathway in colorectal cancer progression.
    Li Y, Zeng C, Hu J, Pan Y, Shan Y, Liu B, Jia L.
    J Hematol Oncol; 2018 Jul 03; 11(1):89. PubMed ID: 29970122
    [Abstract] [Full Text] [Related]

  • 5. Decreased expression of ARHGAP15 promotes the development of colorectal cancer through PTEN/AKT/FOXO1 axis.
    Pan S, Deng Y, Fu J, Zhang Y, Zhang Z, Ru X, Qin X.
    Cell Death Dis; 2018 Jun 04; 9(6):673. PubMed ID: 29867200
    [Abstract] [Full Text] [Related]

  • 6. γ-Glutamyl cyclotransferase contributes to tumor progression in high grade serous ovarian cancer by regulating epithelial-mesenchymal transition via activating PI3K/AKT/mTOR pathway.
    Li Y, Wu T, Wang Y, Yang L, Hu C, Chen L, Wu S.
    Gynecol Oncol; 2018 Apr 04; 149(1):163-172. PubMed ID: 29429592
    [Abstract] [Full Text] [Related]

  • 7. COPS5 and LASP1 synergistically interact to downregulate 14-3-3σ expression and promote colorectal cancer progression via activating PI3K/AKT pathway.
    Zhou R, Shao Z, Liu J, Zhan W, Gao Q, Pan Z, Wu L, Xu L, Ding Y, Zhao L.
    Int J Cancer; 2018 May 01; 142(9):1853-1864. PubMed ID: 29226323
    [Abstract] [Full Text] [Related]

  • 8. Single-cell RNA sequencing in double-hit lymphoma: IMPDH2 induces the progression of lymphoma by activating the PI3K/AKT/mTOR signaling pathway.
    Gao G, Xue Q, He J, Wu M, Jiang Y, Li Q, Zhang Y, Shi W.
    Int Immunopharmacol; 2023 Dec 01; 125(Pt A):111125. PubMed ID: 37907047
    [Abstract] [Full Text] [Related]

  • 9. [LncRNA SNHG11 promotes malignant progression of colorectal cancer cells through the PI3K/Akt/mTOR signaling pathway].
    Tao SN, Liu XC, Wang YY, Yang H.
    Zhonghua Yi Xue Za Zhi; 2024 Mar 12; 104(10):758-765. PubMed ID: 38462356
    [Abstract] [Full Text] [Related]

  • 10. GPR56 promotes proliferation of colorectal cancer cells and enhances metastasis via epithelial‑mesenchymal transition through PI3K/AKT signaling activation.
    Ji B, Feng Y, Sun Y, Ji D, Qian W, Zhang Z, Wang Q, Zhang Y, Zhang C, Sun Y.
    Oncol Rep; 2018 Oct 12; 40(4):1885-1896. PubMed ID: 30066935
    [Abstract] [Full Text] [Related]

  • 11. Actein antagonizes colorectal cancer through blocking PI3K/Akt pathways by downregulating IMPDH2.
    Yan L, Wang D, Liu X, Gu C, Gao S.
    Anticancer Drugs; 2021 Sep 01; 32(8):864-874. PubMed ID: 33929996
    [Abstract] [Full Text] [Related]

  • 12. Tumor suppressive effect of scavenger receptor class A member 5 overexpression in colorectal cancer by regulating PI3K/AKT/mTOR pathway.
    Li Y, Peng F, Tan X, Wang J, Xu Y.
    Genes Genomics; 2021 Oct 01; 43(10):1189-1198. PubMed ID: 34417976
    [Abstract] [Full Text] [Related]

  • 13. Vitexicarpin suppresses malignant progression of colorectal cancer through affecting c-Myc ubiquitination by targeting IMPDH2.
    Ding XJ, Cai XM, Wang QQ, Liu N, Zhong WL, Xi XN, Lu YX.
    Phytomedicine; 2024 Sep 01; 132():155833. PubMed ID: 39008915
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. LncRNA ST3Gal6-AS1/ST3Gal6 axis mediates colorectal cancer progression by regulating α-2,3 sialylation via PI3K/Akt signaling.
    Hu J, Shan Y, Ma J, Pan Y, Zhou H, Jiang L, Jia L.
    Int J Cancer; 2019 Jul 15; 145(2):450-460. PubMed ID: 30613961
    [Abstract] [Full Text] [Related]

  • 16. Leukotriene B4 receptor knockdown affects PI3K/AKT/mTOR signaling and apoptotic responses in colorectal cancer.
    Tang C, Wang A, Zhao Y, Mou W, Jiang J, Kuang J, Sun B, Tang E.
    Biomol Biomed; 2024 Jan 20; 24(4):968-981. PubMed ID: 38259082
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. DCLK1 promotes epithelial-mesenchymal transition via the PI3K/Akt/NF-κB pathway in colorectal cancer.
    Liu W, Wang S, Sun Q, Yang Z, Liu M, Tang H.
    Int J Cancer; 2018 May 15; 142(10):2068-2079. PubMed ID: 29277893
    [Abstract] [Full Text] [Related]

  • 20. Pyrroline-5-Carboxylate Reductase-2 Promotes Colorectal Cancer Progression via Activating PI3K/AKT/mTOR Pathway.
    Yin F, Huang X, Xuan Y.
    Dis Markers; 2021 May 15; 2021():9950663. PubMed ID: 34512817
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 70.